TITLE

Determinants of adults' intention to vaccinate against pandemic swine flu

AUTHOR(S)
Myers, Lynn B.; Goodwin, Robin
PUB. DATE
January 2011
SOURCE
BMC Public Health;2011, Vol. 11 Issue 1, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Vaccination is one of the cornerstones of controlling an influenza pandemic. To optimise vaccination rates in the general population, ways of identifying determinants that influence decisions to have or not to have a vaccination need to be understood. Therefore, this study aimed to predict intention to have a swine influenza vaccination in an adult population in the UK. An extension of the Theory of Planned Behaviour provided the theoretical framework for the study. Methods: Three hundred and sixty two adults from the UK, who were not in vaccination priority groups, completed either an online (n = 306) or pen and paper (n = 56) questionnaire. Data were collected from 30th October 2009, just after swine flu vaccination became available in the UK, and concluded on 31st December 2009. The main outcome of interest was future swine flu vaccination intentions. Results: The extended Theory of Planned Behaviour predicted 60% of adults' intention to have a swine flu vaccination with attitude, subjective norm, perceived control, anticipating feelings of regret (the impact of missing a vaccination opportunity), intention to have a seasonal vaccine this year, one perceived barrier: "I cannot be bothered to get a swine flu vaccination" and two perceived benefits: "vaccination decreases my chance of getting swine flu or its complications" and "if I get vaccinated for swine flu, I will decrease the frequency of having to consult my doctor," being significant predictors of intention. Black British were less likely to intend to have a vaccination compared to Asian or White respondents. Conclusions: Theoretical frameworks which identify determinants that influence decisions to have a pandemic influenza vaccination are useful. The implications of this research are discussed with a view to maximising any future pandemic influenza vaccination uptake using theoretically-driven applications.
ACCESSION #
58027178

 

Related Articles

  • Healthcare Worker Acceptance of Pandemic (H1N1) 2009 Vaccination, Morocco. Tagajdid, Rida; El Annaz, Hicham; Doblali, Taoufik; Sefiani, Kawtar; Belfquih, Bouchra; Mrani, Saad // Emerging Infectious Diseases;Oct2010, Vol. 16 Issue 10, p1638 

    A letter to the editor is presented about a survey of healthcare workers on the acceptance of pandemic H1N1 2009 vaccination in Morocco conducted from January 15 to February 28, 2010.

  • Vical gets good H1N1 pandemic FLU Vaccine Phase 1.  // Biotech Business;Jun2011, Vol. 24 Issue 6, p7 

    The article discusses the favorable Phase 1 trial of Vical Incorporated's Vaxfectin (R)-formulated vaccine for H1N1 pandemic influenza. It reports that the vaccine generated neutralizing antibodies demonstrating its safety and immunogenicity in humans. Information presented states that the trial...

  • Factors associated with parental acceptance and refusal of pandemic influenza A/H1N1 vaccine in Turkey. Akıs, Sule; Velıpasaoglu, Sevtap; Camurdan, Aysu; Beyazova, Ufuk; Sahın, Figen; Akis, Sule; Velipasaoglu, Sevtap; Camurdan, Aysu Duyan; Sahn, Figen // European Journal of Pediatrics;Sep2011, Vol. 170 Issue 9, p1165 

    The objective of this study was to investigate the parents' attitudes towards and identify the possible factors associated with pandemic H1N1 vaccine uptake that was recommended to children between 6 months and 5 years of age. A questionnaire exploring the attitudes of parents to H1N1 vaccine...

  • 2009 H1N1 Vaccination in Minnesota. MUSCOPLAT, MIRIAM HALSTEAD; RODDY, MARGARET; PARILLA, ELIZABETH; DAVEY, CYNTHIA S.; FLEEGE, LAURA; WHITE, KAREN; EHRESMANN, KRISTEN // Minnesota Medicine;Sep2013, Vol. 96 Issue 9, p49 

    According to Minnesota Immunization Information Connection (MIIC) data, 23% of Minnesotans were vaccinated against 2009 pandemic H1N1 influenza. We analyzed 2009 H1N1 vaccination data at the ZIP code level to learn more about who received the vaccine between 2009 and 2010. We found significant...

  • Trust in medical organizations predicts pandemic (H1N1) 2009 vaccination behavior and perceived efficacy of protection measures in the Swiss public. Gilles, Ingrid; Bangerter, Adrian; Clémence, Alain; Green, Eva; Krings, Franciska; Staerklé, Christian; Wagner-Egger, Pascal // European Journal of Epidemiology; 

    Following the recent avian influenza and pandemic (H1N1) 2009 outbreaks, public trust in medical and political authorities is emerging as a new predictor of compliance with officially recommended protection measures. In a two-wave longitudinal survey of adults in French-speaking Switzerland,...

  • Publication Delay of Randomized Trials on 2009 Influenza A (H1N1) Vaccination Ioannidis, John P. A.; Manzoli, Lamberto; De Vito, Corrado; D'Addario, Maddalena; Villari, Paolo // PLoS Clinical Trials;Dec2011, Vol. 6 Issue 12, p1 

    Background: Randomized evidence for vaccine immunogenicity and safety is urgently needed in the setting of pandemics with new emerging infectious agents. We carried out an observational survey to evaluate how many randomized controlled trials testing 2009 H1N1 vaccines were published among...

  • A Candidate H1N1 Pandemic Influenza Vaccine Elicits Protective Immunity in Mice. Steitz, Julia; Barlow, Peter G.; Hossain, Jaber; Eun Kim; Okada, Kaori; Kenniston, Tom; Rea, Sheri; Donis, Ruben O.; Gambotto, Andrea // PLoS ONE;2010, Vol. 5 Issue 5, p1 

    Background: In 2009 a new pandemic disease appeared and spread globally. The recent emergence of the pandemic influenza virus H1N1 first isolated in Mexico and USA raised concerns about vaccine availability. We here report our development of an adenovirus-based influenza H1N1 vaccine tested for...

  • Factors influencing H1N1 vaccine behavior among Manitoba Metis in Canada: a qualitative study. Driedger, S. Michelle; Maier, Ryan; Furgal, Chris; Jardine, Cindy // BMC Public Health;2015, Vol. 15 Issue 1, p1 

    Background: During the first wave of the H1N1 influenza pandemic in 2009, Aboriginal populations in Canada experienced disproportionate rates of infection, particularly in the province of Manitoba. To protect those thought to be most at-risk, health authorities in Manitoba listed all Aboriginal...

  • Association Between Seasonal Influenza Vaccination in 2008-2009 and Pandemic Influenza A (H1N1) 2009 Infection Among School Students From Kobe, Japan, April-June 2009. Tsuchihashi, Yuuki; Sunagawa, Tomimasa; Yahata, Yuichiro; Takahashi, Hideaki; Toyokawa, Takao; Odaira, Fumito; Ohyama, Takaaki; Taniguchi, Kiyosu; Okabe, Nobuhiko // Clinical Infectious Diseases;2/1/2012, Vol. 54 Issue 3, p381 

    We assessed the effect of seasonal trivalent inactivated influenza vaccination (TIV) on pandemic influenza 2009 (pH1N1)-related illness from April to June 2009 among 2849 students (aged 12-18 years). TIV was associated with an increase in the frequency of pH1N1-related illness among subjects...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics